Data Governance Framework Design

Data governance framework design, master data management, data ownership structures and data lineage reviews for pharmaceutical, biotechnology and medical device organisations — creating the organisational infrastructure that makes data integrity sustainable.

Executive Overview

Data integrity in regulated environments is not achieved through technical controls alone. Systems can be configured correctly, audit trails can be enabled and electronic signatures can be implemented — yet data integrity failures still occur when the organisational structures for data management are absent. Data governance provides those structures: clear ownership, defined standards, systematic quality monitoring and accountable stewardship for the data that regulatory compliance depends on.

Regulatory authorities including the MHRA, FDA and EMA have all published guidance emphasising that data governance is a prerequisite for data integrity. Organisations expected to demonstrate ALCOA+ compliance must be able to show not only that individual data points are accurate, but that systematic controls exist to ensure data quality across all systems, all processes and all product types — over time, not just at a point in time.

Sthira Assure designs data governance frameworks that address the specific requirements of pharmaceutical, biotechnology and medical device organisations. Our frameworks define data ownership and stewardship structures, establish data classification and handling standards, design master data management processes and create data quality programmes that provide ongoing assurance — not just periodic audits.

Regulatory Frameworks

MHRA Data Integrity Guidance
FDA Data Integrity Guidance
PIC/S DI Guidance (PI 041)
WHO Data Integrity Guidelines
EU GMP Annex 11
ICH Q10 (Quality System)
GAMP 5 Records & Data

Design Your Data Governance Framework

Speak with our team about your data governance requirements.

Request a Consultation

Common Compliance Risks

No Formal Data Governance Structure

Many pharmaceutical and medical device organisations manage GxP data without a formal governance framework — no defined data ownership, no documented data classification, no systematic approach to data quality and no structure for resolving data conflicts or quality issues. The absence of formal governance makes data integrity assurance impossible to demonstrate systematically, a position that is increasingly difficult to defend during regulatory inspections.

Master Data Inconsistency Across Systems

Organisations operating multiple systems — ERP, LIMS, MES, eQMS, EHR — frequently maintain inconsistent master data sets: different product descriptions, inconsistent supplier records, misaligned batch numbering conventions. Master data inconsistency creates both data integrity risks and operational errors. In regulated environments, inconsistent data across systems is a specific regulatory concern, as it undermines the reliability and traceability of quality records.

Undefined Data Ownership and Accountability

When no one is formally accountable for a data set's quality, completeness and regulatory compliance, data quality deteriorates over time. Fields go unpopulated, classification conventions diverge between users, historical records are inconsistently maintained and data integrity issues are discovered reactively rather than prevented proactively. Defined data ownership and stewardship structures create systematic accountability for data quality across the organisation.

Inadequate Data Lineage for Regulatory Submissions

Regulatory submissions — whether marketing authorisation applications, annual product reviews or variation submissions — rely on data that has been collected, processed and analysed across multiple systems. If the lineage of this data — the chain of transformations from raw source data to regulatory output — cannot be documented and verified, the integrity of the submission data cannot be demonstrated. Data lineage reviews identify gaps in traceability before they affect regulatory filings.

Scope of Services

Data governance framework design and implementation

Master data governance programme design

Metadata management strategy and review

Data lineage mapping and traceability reviews

Data ownership and stewardship structure design

Data classification and handling framework

Data governance policy and procedure development

Data quality programme design and assessment

Third-party data governance oversight frameworks

Typical Deliverables

→Data Governance Framework Document

→Data Ownership and Stewardship Charter

→Master Data Governance Policy and Procedures

→Data Classification Matrix

→Data Lineage Map and Traceability Assessment

→Metadata Management Framework

→Data Governance Implementation Roadmap

→Data Quality Assessment Report

Frequently Asked Questions

What is data governance in the context of pharmaceutical organisations?

Data governance in pharmaceutical organisations is the set of policies, roles, responsibilities and processes that define how GxP and business-critical data is created, managed, protected and used throughout its lifecycle. It encompasses data ownership (who is accountable), data classification (what level of protection and control applies), data quality standards (what constitutes acceptable data), data lineage (where data comes from and how it is transformed) and data retention (how long data is kept and in what form).

Is data governance the same as data integrity?

Data governance and data integrity are related but distinct concepts. Data integrity, in the regulatory sense, refers to the completeness, consistency and accuracy of GxP data throughout its lifecycle — aligned to ALCOA+ principles. Data governance is the broader organisational framework that enables data integrity to be maintained systematically. Effective data governance creates the structures and accountabilities that make data integrity possible; data integrity is the compliance outcome that governance enables.

Who should be responsible for data governance in a pharmaceutical organisation?

Data governance requires cross-functional ownership. A data governance framework typically defines a Data Governance Council or Committee with representation from Quality, IT, Regulatory Affairs, Manufacturing and relevant business functions. This body sets policy and resolves data governance decisions. Data Stewards in individual functions are responsible for the quality and compliance of specific data domains within their area — master batch records, analytical data, regulatory data sets. IT provides technical infrastructure support.

How does data governance relate to inspections?

Regulators increasingly examine data governance as part of broader data integrity inspections. FDA warning letters and EMA inspection deficiency letters cite not only specific data integrity violations but also the absence of organisational structures to prevent them — no data ownership, no data quality monitoring, no training on data standards. A documented data governance framework demonstrates that the organisation has systematically addressed the root causes of data integrity risk, not just individual instances.

Build Sustainable Data Governance

Contact our team to discuss your data governance requirements and the framework your organisation needs for sustainable data integrity compliance.

Request a Consultation View Data Integrity Services